A study to determine the effect of AF-219 on the urge to cough in patients with long-term cough

Registry ID

EUCTR2015-002034-47

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Afferent Pharmaceuticals, Inc.

Start date

2015-07-27

Completion date

2016-10-20

Last update

2026-08-16

Conditions

• Chronic cough

Summary

To assess the effect of of a twice daily dose of 100 mg AF-219 on cough reflex sensitivity in both healthy and chronic cough subjects

Locations

• , , UK

View on source registry